feed,title,long_url,short_url
Benzinga,ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactions,https://benzinga.com/analyst-ratings/analyst-color/24/02/37221031/ars-pharma-readies-data-in-response-to-fdas-rejection-for-its-epipen-alternative-fo,https://da.gd/WFFkxG
